These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35610178)

  • 21. Receptor-binding profiles of antipsychotics: clinical strategies when switching between agents.
    Buckley PF
    J Clin Psychiatry; 2007; 68 Suppl 6():5-9. PubMed ID: 17650053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, docking and pharmacological evaluation of novel indole based potential atypical antipsychotics.
    Bali A; Sen U; Peshin T
    Eur J Med Chem; 2014 Mar; 74():477-90. PubMed ID: 24495776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Antipsychotic D2AAK1 as a Memory Enhancer for Treatment of Mental and Neurodegenerative Diseases.
    Koszła O; Sołek P; Woźniak S; Kędzierska E; Wróbel TM; Kondej M; Archała A; Stępnicki P; Biała G; Matosiuk D; Kaczor AA
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropharmacological profile of an atypical antipsychotic, NRA0562.
    Hirota S; Kawashima N; Chaki S; Okuyama S
    CNS Drug Rev; 2003; 9(4):375-88. PubMed ID: 14647530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multifunctional 6-fluoro-3-[3-(pyrrolidin-1-yl)propyl]-1,2-benzoxazoles targeting behavioral and psychological symptoms of dementia (BPSD).
    Bucki A; Marcinkowska M; Śniecikowska J; Zagórska A; Jamrozik M; Pawłowski M; Głuch-Lutwin M; Siwek A; Jakubczyk M; Pytka K; Jastrzębska-Więsek M; Partyka A; Wesołowska A; Mierzejewski P; Kołaczkowski M
    Eur J Med Chem; 2020 Apr; 191():112149. PubMed ID: 32105980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of 5-HT2A receptors in antipsychotic activity.
    Schmidt CJ; Sorensen SM; Kehne JH; Carr AA; Palfreyman MG
    Life Sci; 1995; 56(25):2209-22. PubMed ID: 7791509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurochemical alterations in schizophrenia affecting the putative receptor targets of atypical antipsychotics. Focus on dopamine (D1, D3, D4) and 5-HT2a receptors.
    Harrison PJ
    Br J Psychiatry Suppl; 1999; (38):12-22. PubMed ID: 10884896
    [No Abstract]   [Full Text] [Related]  

  • 28. Sertindole for the treatment of schizophrenia.
    Azorin JM; Kaladjian A; Fakra E; Adida M
    Expert Opin Pharmacother; 2010 Dec; 11(18):3053-64. PubMed ID: 21080854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, Synthesis and Biological Investigation of Flavone Derivatives as Potential Multi-Receptor Atypical Antipsychotics.
    Gao L; Yang Z; Xiong J; Hao C; Ma R; Liu X; Liu BF; Jin J; Zhang G; Chen Y
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32911828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and Biological Evaluation of Fused Tricyclic Heterocycle Piperazine (Piperidine) Derivatives As Potential Multireceptor Atypical Antipsychotics.
    Cao X; Zhang Y; Chen Y; Qiu Y; Yu M; Xu X; Liu X; Liu BF; Zhang L; Zhang G
    J Med Chem; 2018 Nov; 61(22):10017-10039. PubMed ID: 30383372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors for developing effective antipsychotics: synthesis, biological characterization, and behavioral studies.
    Brindisi M; Butini S; Franceschini S; Brogi S; Trotta F; Ros S; Cagnotto A; Salmona M; Casagni A; Andreassi M; Saponara S; Gorelli B; Weikop P; Mikkelsen JD; Scheel-Kruger J; Sandager-Nielsen K; Novellino E; Campiani G; Gemma S
    J Med Chem; 2014 Nov; 57(22):9578-97. PubMed ID: 25343529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular targets for treating cognitive dysfunction in schizophrenia.
    Gray JA; Roth BL
    Schizophr Bull; 2007 Sep; 33(5):1100-19. PubMed ID: 17617664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Natural Product with High Affinity to Sigma and 5-HT
    Wang L; Zhang Y; Wang C; Zhang X; Wang Z; Liang X; Alachkar A; Civelli O
    Neurochem Res; 2019 Nov; 44(11):2536-2545. PubMed ID: 31529334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.
    Kapur S; Seeman P
    Am J Psychiatry; 2001 Mar; 158(3):360-9. PubMed ID: 11229973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical puzzles in the search for new, flexible derivatives of lurasidone as antipsychotic drugs.
    Zaręba P; Drabczyk AK; Jaśkowska J; Satała G
    Bioorg Med Chem; 2020 May; 28(10):115459. PubMed ID: 32247749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonin receptors: their key role in drugs to treat schizophrenia.
    Meltzer HY; Li Z; Kaneda Y; Ichikawa J
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1159-72. PubMed ID: 14642974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential role of muscarinic receptors in schizophrenia.
    Bymaster FP; Shannon HE; Rasmussen K; DeLapp NW; Ward JS; Calligaro DO; Mitch CH; Whitesitt C; Ludvigsen TS; Sheardown M; Swedberg M; Rasmussen T; Olesen PH; Jeppesen L; Sauerberg P; Fink-Jensen A
    Life Sci; 1999; 64(6-7):527-34. PubMed ID: 10069519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological and molecular targets in the search for novel antipsychotics.
    Scatton B; Sanger DJ
    Behav Pharmacol; 2000 Jun; 11(3-4):243-56. PubMed ID: 11103879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and pharmacological evaluation of piperidine (piperazine)-amide substituted derivatives as multi-target antipsychotics.
    Huang L; Gao L; Zhang X; Yin L; Hu J; Song T; Chen Y
    Bioorg Med Chem Lett; 2020 Oct; 30(20):127506. PubMed ID: 32828898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serotonin-glutamate and serotonin-dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins.
    de Bartolomeis A; Buonaguro EF; Iasevoli F
    Psychopharmacology (Berl); 2013 Jan; 225(1):1-19. PubMed ID: 23179966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.